THERAPEUTIC LIST
Oncology Drug List
| S.No. | Therapeutic Name | Short Description | No of Drugs | Therapeutic Drug Price | Action | |
|---|---|---|---|---|---|---|
| 1 | Oncology | 16 | 200.00 | BUY | Your Query | |
| S.No. | Updated On | Drug | Price in USD | Action | ||
|---|---|---|---|---|---|---|
| 1 | Jun, 2020 | AdroGel Drug Sales AndroGel (testosterone gel) is a testosterone replacement therapy for males diagnosed with symptomatic low testosterone due to certain underlying conditio.... | 15.00 | READ | BUY | Your Query |
| 2 | Jun, 2020 | Creon Drug Sales & Forecast Creon (pancrelipase) is a pancreatic enzyme therapy for exocrine pancreatic insufficiency, a condition that occurs in patients with cystic fibrosis, chron.... | 15.00 | READ | BUY | Your Query |
| 3 | Jun, 2020 | Empliciti Drug Sales & Forecast BMS and AbbVie jointly develop and commercialize Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma. Both parties participat.... | 15.00 | READ | BUY | Your Query |
| 4 | Jun, 2020 | Opdivo/Yervoy Drug Sales & Forecast Opdivo is a programmed death-1 (PD-1) immune checkpoint inhibitor that is designed to uniquely harness the body’s own immune system to help restore anti.... | 15.00 | READ | BUY | Your Query |
| 5 | May, 2020 | Tecentriq Drug Sales & Forecast Roche drug Tecentriq is a cancer immunotherapy that has the potential to be used as a foundational combination partner with other immunotherapies, targete.... | 15.00 | READ | BUY | Your Query |
| 6 | May, 2020 | Alecensa Drug Sales & Forecast Roche drug Alecensa is a highly selective, CNS active, oral medicine created at Chugai Kamakura Research Laboratories and is being developed for people wi.... | 15.00 | READ | BUY | Your Query |
| 7 | May, 2020 | Avastin Drug Sales & Forecast Roche drug Avastin is a prescription-only medicine that is a solution for intravenous infusion. It is a biologic antibody designed to specifically bind to.... | 15.00 | READ | BUY | Your Query |
| 8 | Apr, 2020 | Keytruda Drug Sales & Forecast Merck drug Keytruda is used for the treatment of multiple types of cancer such as non-small-cell lung cancer (NSCLC), small-cell lung cancer (SCLC), head .... | 15.00 | READ | BUY | Your Query |
| 9 | Apr, 2020 | Imbruvica Drug Sales & Forecast Johnson & Johnson drug Imbruvica (ibrutinib) is an oral, once-daily medicine that works differently than chemotherapy as it blocks a protein called Bruton.... | 15.00 | READ | BUY | Your Query |
| 10 | Apr, 2020 | Darzalex Drug Sales & Forecast Johnson & Johnson drug Darzalex (daratumumab) is a prescription medicine used to treat a type of blood cancer called multiple myeloma. Darzalex is not che.... | 15.00 | READ | BUY | Your Query |
| 11 | Apr, 2020 | Yescarta Drug Sales & Forecast GileadSciences drug Yescarta (axicabtagene ciloleucel) is a (chimeric antigen receptor cell therapy) CAR-T for the treatment of adult patients with relaps.... | 15.00 | READ | BUY | Your Query |
| 12 | Apr, 2020 | Zejula Drug Sales & Forecast Zejula, GlaxoSmithKline (GSK) oral PARP inhibitor, is approved in the United States and Europe for women with recurrent ovarian cancer. MNG Tracker report.... | 15.00 | READ | BUY | Your Query |
| 13 | Apr, 2020 | Alimta Drug Sales & Forecast Eli Lilly drug Alimta is used for the treatment of lung cancer. Its vitamin regimen patent plus pediatric exclusivity will expire in May 2022 in United St.... | 20.00 | READ | BUY | Your Query |
| 14 | Mar, 2020 | Lynparza Drug Sales & Forecast AstraZeneca drug Lynparza became the world’s ¬first approved PARP inhibitor in 2014. Initially indicated for the treatment of ovarian cancer, in 2017, .... | 20.00 | READ | BUY | Your Query |
| 15 | Mar, 2020 | Imfinzi Drug Sales & Forecast AstraZeneca drug Imfinzi is approved for lung and bladder cancer in 2017. Imfinzi, a human mAb that binds to PD-L1 and blocks the interaction of PD-L1 wit.... | 20.00 | READ | BUY | Your Query |
| 16 | Mar, 2020 | Tagrisso Drug Sales & Forecast AstraZeneca drug Tagrisso is approved for lung cancer in 2015. Tagrisso is a best-in-class, highly selective, irreversible inhibitor of the activating sen.... | 20.00 | READ | BUY | Your Query |
